- Home
- DCI vs PCVX Comparison
DCI vs PCVX Comparison
Compare DCI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCI
- PCVX
- Stock Information
- Founded
- DCI 1915
- PCVX 2013
- Country
- DCI United States
- PCVX United States
- Employees
- DCI N/A
- PCVX N/A
- Industry
- DCI Pollution Control Equipment
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- DCI Industrials
- PCVX Health Care
- Exchange
- DCI Nasdaq
- PCVX Nasdaq
- Market Cap
- DCI 9.6B
- PCVX 4.0B
- IPO Year
- DCI 1987
- PCVX 2020
- Fundamental
- Price
- DCI $83.24
- PCVX $42.33
- Analyst Decision
- DCI Hold
- PCVX Strong Buy
- Analyst Count
- DCI 3
- PCVX 8
- Target Price
- DCI $80.33
- PCVX $114.17
- AVG Volume (30 Days)
- DCI 442.4K
- PCVX 1.8M
- Earning Date
- DCI 12-02-2025
- PCVX 11-05-2025
- Dividend Yield
- DCI 1.44%
- PCVX N/A
- EPS Growth
- DCI N/A
- PCVX N/A
- EPS
- DCI 3.05
- PCVX N/A
- Revenue
- DCI $3,690,900,000.00
- PCVX N/A
- Revenue This Year
- DCI $4.36
- PCVX N/A
- Revenue Next Year
- DCI $4.52
- PCVX N/A
- P/E Ratio
- DCI $27.30
- PCVX N/A
- Revenue Growth
- DCI 2.92
- PCVX N/A
- 52 Week Low
- DCI $57.45
- PCVX $27.66
- 52 Week High
- DCI $84.56
- PCVX $116.00
- Technical
- Relative Strength Index (RSI)
- DCI 58.01
- PCVX 60.91
- Support Level
- DCI $82.51
- PCVX $41.24
- Resistance Level
- DCI $84.42
- PCVX $43.45
- Average True Range (ATR)
- DCI 1.53
- PCVX 1.71
- MACD
- DCI -0.02
- PCVX -0.33
- Stochastic Oscillator
- DCI 73.28
- PCVX 40.24
About DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.